Long-term improvement of lung clearance index in patients with mild cystic fibrosis lung disease: Does hypertonic saline play a role?

Journal of Cystic Fibrosis

Volumn 15, Issue 1, 2016, Pages 123-126

  Ellemunter, Helmut ^a,b   Eder, Johannes ^a,b   Fuchs, Susanne ^c   Gappa, Monika ^c   Steinkamp, Gratiana ^d  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Cystic Fibrosis   (Austria)

^c MARIEN HOSPITAL WESEL   (Germany)

^d Clinical Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHLORIDE; DEMULCENT AGENT;

ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE COURSE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GENERAL CONDITION IMPROVEMENT; HUMAN; LONG TERM CARE; LONGITUDINAL STUDY; LUNG CLEARANCE; MALE; RETROSPECTIVE STUDY; SPIROMETRY; DRUG EFFECTS; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; MUCOCILIARY CLEARANCE; PATHOPHYSIOLOGY; PATIENT ACUITY; PROCEDURES; TIME; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; CHILD; CYSTIC FIBROSIS; DEMULCENTS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MUCOCILIARY CLEARANCE; PATIENT ACUITY; RESPIRATORY FUNCTION TESTS; SALINE SOLUTION, HYPERTONIC; TIME; TREATMENT OUTCOME;

EID: 84959530122     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2015.06.009     Document Type: Article

References (16)

1. Tiddens H.A., Rosenow T. What did we learn from two decades of chest computed tomography in cystic fibrosis?. Pediatr Radiol 2014, 44(12):1490-1495.
2. Gustafsson P.M., Aurora P., Lindblad A. Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis. Eur Respir J 2003, 22:972-979.
3. Owens C.M., Aurora P., Stanojevic S., Bush A., Wade A., Oliver C., et al. Lung Clearance Index and HRCT are complementary markers of lung abnormalities in young children with CF. Thorax 2011, 66:481-488.
4. Ellemunter H., Fuchs S.I., Unsinn K.M., Freund M.C., Waltner-Romen M., Steinkamp G., et al. Sensitivity of lung clearance index and chest computed tomography in early CF lung disease. Respir Med 2010, 104:1834-1842.
5. Fuchs S.I., Gappa M., Eder J., Unsinn K.M., Steinkamp G., Ellemunter H. Tracking Lung Clearance Index and chest CT in mild cystic fibrosis lung disease over a period of three years. Respir Med 2014, 108(6):865-874.
6. Donaldson S.H., Bennett W.D., Zeman K.L., Knowles M.R., Tarran R., Boucher R.C. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 2006, 354:241-250.
7. Elkins M.R., Robinson M., Rose B.R., Harbour C., Moriarty C.P., Marks G.B., et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006, 354:229-240.
8. Miller M.R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., et al. Standardisation of spirometry. Eur Respir J 2005, 26:319-338.
9. Quanjer P.H., Tammeling G.J., Cotes J.E., Pedersen O.F., Peslin R., Yernault J.C. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993, 16:5-40.
10. Kent L., Reix P., Innes J.A., Zielen S., Le B.M., Braggion C., et al. Lung clearance index: Evidence for use in clinical trials in cystic fibrosis. J Cyst Fibros 2014, 13:123-138.
11. Konstan M.W., Morgan W.J., Butler S.M., Pasta D.J., Craib M.L., Silva S.J., et al. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr 2007, 151:134-139.
12. Fuchs S.I., Eder J., Ellemunter H., Gappa M. Lung clearance index: Normal values, repeatability, and reproducibility in healthy children and adolescents. Pediatr Pulmonol 2009, 44:1180-1185.
13. Subbarao P., Stanojevic S., Brown M., Jensen R., Rosenfeld M., Davis S., et al. Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline. Am J Respir Crit Care Med 2013, 188:456-460.
14. Amin R., Subbarao P., Jabar A., Balkovec S., Jensen R., Kerrigan S., et al. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function. Thorax 2010, 65:379-383.
15. Ellemunter H., Eder J., Steinkamp G. Structured care in an ISO certified centre for patients with cystic fibrosis and their families. Pneumologie 2011, 65:615-623.
16. Kerem E., Conway S., Elborn S., Heijerman H. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros 2005, 4:7-26.